Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke

被引:77
作者
Zerche, Maria [1 ]
Weissenborn, Karin [2 ]
Ott, Christoph [1 ]
Dere, Ekrem [1 ]
Asif, Abdul R. [4 ]
Worthmann, Hans [2 ]
Hassouna, Imam [1 ]
Rentzsch, Kristin [5 ]
Tryc, Anita B. [2 ]
Dahm, Liane [1 ]
Steiner, Johann [6 ]
Binder, Lutz [4 ]
Wiltfang, Jens [3 ,7 ]
Siren, Anna-Leena [8 ]
Stoecker, Winfried [5 ]
Ehrenreich, Hannelore [1 ]
机构
[1] Max Planck Inst Expt Med, Clin Neurosci, D-37075 Gottingen, Germany
[2] Hannover Med Sch, Dept Neurol, Hannover, Germany
[3] DFG Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany
[4] Univ Med Ctr, Inst Clin Chem, Gottingen, Germany
[5] Inst Expt Immunol, Affiliated Euroimmun, Lubeck, Germany
[6] Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany
[7] Univ Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany
[8] Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany
关键词
apolipoprotein E4; blood-brain barrier; immunoglobulin class; BLOOD-BRAIN-BARRIER; RECEPTOR-ENCEPHALITIS; ANTIBODIES; DISEASE; E4; SEROPREVALENCE; PATHOBIOLOGY; CYCLOPHILIN; PREVALENCE; PREDICTION;
D O I
10.1161/STROKEAHA.114.008323
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Recently, we reported high seroprevalence (age-dependent up to > 19%) of N-methyl-D-aspartate-receptor subunit NR1 (NMDAR1) autoantibodies in both healthy and neuropsychiatrically ill subjects (N=4236). Neuropsychiatric syndrome relevance was restricted to individuals with compromised blood-brain barrier, for example, apolipoprotein E4 (APOE4) carrier status, both clinically and experimentally. We now hypothesized that these autoantibodies may upon stroke be protective in individuals with hitherto intact blood-brain barrier, but harmful for subjects with chronically compromised blood-brain barrier. Methods-Of 464 patients admitted with acute ischemic stroke in the middle cerebral artery territory, blood for NMDAR1 autoantibody measurements and APOE4 carrier status as indicator of a preexisting leaky blood-brain barrier was collected within 3 to 5 hours after stroke. Evolution of lesion size (delta day 7-1) in diffusion-weighted magnetic resonance imaging was primary outcome parameter. In subgroups, NMDAR1 autoantibody measurements were repeated on days 2 and 7. Results-Of all 464 patients, 21.6% were NMDAR1 autoantibody-positive (immunoglobulin M, A, or G) and 21% were APOE4 carriers. Patients with magnetic resonance imaging data available on days 1 and 7 (N=384) were divided into 4 groups according to NMDAR1 autoantibody and APOE4 status. Groups were comparable in all stroke-relevant presenting characteristics. The autoantibody+/APOE4-group had a smaller mean delta lesion size compared with the autoantibody-/APOE4-group, suggesting a protective effect of circulating NMDAR1 autoantibodies. In contrast, the autoantibody+/APOE4+ group had the largest mean delta lesion area. NMDAR1 autoantibody serum titers dropped on day 2 and remounted by day 7. Conclusions-Dependent on blood-brain barrier integrity before an acute ischemic brain injury, preexisting NMDAR1 autoantibodies seem to be beneficial or detrimental.
引用
收藏
页码:1180 / 1186
页数:7
相关论文
共 34 条
[1]   Human apolipoprotein E ε4 expression impairs cerebral vascularization and blood-brain barrier function in mice [J].
Alata, Wael ;
Ye, Yue ;
St-Amour, Isabelle ;
Vandal, Milene ;
Calon, Frederic .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2015, 35 (01) :86-94
[2]  
[Anonymous], 1958, Ph.D. Thesis
[3]   Change in Diffusion-Weighted Imaging Infarct Volume Predicts Neurologic Outcome at 90 Days Results of the Acute Stroke Accurate Prediction (ASAP) Trial Serial Imaging Substudy [J].
Barrett, Kevin M. ;
Ding, Yong Hong ;
Wagner, Douglas P. ;
Kallmes, David F. ;
Johnston, Karen C. .
STROKE, 2009, 40 (07) :2422-2427
[4]   Apolipoprotein E controls cerebrovascular integrity via cyclophilin A [J].
Bell, Robert D. ;
Winkler, Ethan A. ;
Singh, Itender ;
Sagare, Abhay P. ;
Deane, Rashid ;
Wu, Zhenhua ;
Holtzman, David M. ;
Betsholtz, Christer ;
Armulik, Annika ;
Sallstrom, Jan ;
Berk, Bradford C. ;
Zlokovic, Berislav V. .
NATURE, 2012, 485 (7399) :512-516
[5]   Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients [J].
Busse, Stefan ;
Busse, Mandy ;
Brix, Britta ;
Probst, Christian ;
Genz, Axel ;
Bogerts, Bernhard ;
Stoecker, Winfried ;
Steiner, Johann .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2014, 264 (06) :545-550
[6]   Do Neuronal Autoantibodies Cause Psychosis? A Neuroimmunological Perspective [J].
Coutinho, Ester ;
Harrison, Paul ;
Vincent, Angela .
BIOLOGICAL PSYCHIATRY, 2014, 75 (04) :269-275
[7]   Seroprevalence of Autoantibodies against Brain Antigens in Health and Disease [J].
Dahm, Liane ;
Ott, Christoph ;
Steiner, Johann ;
Stepniak, Beata ;
Teegen, Bianca ;
Saschenbrecker, Sandra ;
Hammer, Christian ;
Borowski, Kathrin ;
Begemann, Martin ;
Lemke, Sandra ;
Rentzsch, Kristin ;
Probst, Christian ;
Martens, Henrik ;
Wienands, Juergen ;
Spalletta, Gianfranco ;
Weissenborn, Karin ;
Stoecker, Winfried ;
Ehrenreich, Hannelore .
ANNALS OF NEUROLOGY, 2014, 76 (01) :82-94
[8]   Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies [J].
Dalmau, Josep ;
Gleichman, Amy J. ;
Hughes, Ethen G. ;
Rossi, Jeffrey E. ;
Peng, Xiaoyu ;
Lai, Meizan ;
Dessain, Scott K. ;
Rosenfeld, Mynna R. ;
Balice-Gordon, Rita ;
Lynch, David R. .
LANCET NEUROLOGY, 2008, 7 (12) :1091-1098
[9]   Losing your nerves? Maybe it's the antibodies [J].
Diamond, Betty ;
Huerta, Patricio T. ;
Mina-Osorio, Paola ;
Kowal, Czeslawa ;
Volpe, Bruce T. .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (06) :449-456
[10]   Pathobiology of ischaemic stroke: an integrated view [J].
Dirnagl, U ;
Iadecola, C ;
Moskowitz, MA .
TRENDS IN NEUROSCIENCES, 1999, 22 (09) :391-397